Correlation Between Handa Pharmaceuticals and DV Biomed

Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and DV Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and DV Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Handa Pharmaceuticals and DV Biomed Co, you can compare the effects of market volatilities on Handa Pharmaceuticals and DV Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of DV Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and DV Biomed.

Diversification Opportunities for Handa Pharmaceuticals and DV Biomed

0.7

Correlation Coefficient

Handa Pharmaceuticals  DV Biomed

Poor diversification

The 3 months correlation between Handa and 6539 is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and DV Biomed Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DV Biomed and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with DV Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DV Biomed has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and DV Biomed go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and DV Biomed

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to under-perform the DV Biomed. In addition to that, Handa Pharmaceuticals is 2.49 times more volatile than DV Biomed Co. It trades about -0.27 of its total potential returns per unit of risk. DV Biomed Co is currently generating about -0.07 per unit of volatility. If you would invest  7,000  in DV Biomed Co on September 5, 2024 and sell it today you would lose (330.00) from holding DV Biomed Co or give up 4.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Handa Pharmaceuticals  vs.  DV Biomed Co

Handa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

DV Biomed

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DV Biomed Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, DV Biomed is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Handa Pharmaceuticals and DV Biomed

The main advantage of trading using opposite Handa Pharmaceuticals and DV Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, DV Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will offset losses from the drop in DV Biomed's long position.

The idea behind Handa Pharmaceuticals and DV Biomed Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..